Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
Tachibana
T
T
Takasaki
H
H
Tanaka
M
M
Maruta
A
A
Hyo
R
R
Ishigatsubo
Y
Y
Kanamori
H
H
D000293:Adolescent; D000328:Adult; D000465:Algorithms; D000753:Anemia, Refractory / Q000150:complications*; D005260:Female; D005293:Ferritins / Q000097:blood*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D019190:Iron Overload / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D012074:Remission Induction; D012307:Risk Factors; D016019:Survival Analysis; D014184:Transplantation, Homologous; D055815:Young Adult
D005293:Ferritins